Veradigm | MDRX - Ebit

Prezzo Delle Azioni
4.58
Cambio Giornaliero
-0.07 -1.40%
Mensile
1.78%
Annuale
7.76%
Q1 Previsione
4.44




Ebit Cambiamento Data
Alcidion AUD 2.2M 1.76M 2025-12
Ambu A/S DKK 168M 21M 2025-12
Amplifon EUR 26.28M 39.26M 2025-09
Cardinal Health USD 763M 9M 2025-12
Centene USD -1.23B 1.03B 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Cigna USD 2.58B 220M 2025-09
Coloplast 1.85B 102M 2025-12
Convatec Group USD 262.5M 39.7M 2024-12
CVS Health USD 2.11B 836M 2025-12
Diasorin EUR 56.68M 13.53M 2025-09
Elevance Health USD 581M 1.18B 2025-12
General Electric Aerospace USD 1.68B 429M 2025-12
Gulf Medical Proj AED 30.8M 8.97M 2025-12
Humana USD -808M 1.21B 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 382M 11M 2025-12
Maximus USD 146.21M 23.31M 2025-12
McKesson USD 1.66B 159M 2025-12
Med Life RON 40.09M 34.8M 2025-09
Molina Healthcare USD -153M 293M 2025-12
Omnicell USD 1.18M 9.81M 2025-12
Oriola-kd EUR 5.4M 1.2M 2025-12
Owens Minor USD 814K 28.08M 2025-12
Quest Diagnostics USD 386M 0 2025-12
Rede D'or Sao Luiz BRL 2.56B 230.77M 2025-12
Siemens Healthineers EUR 677M 214M 2025-12
Sonova Holding CHF 296.8M 156.9M 2025-12
Supermax Corporation Bhd MYR -63.56M 79.6M 2025-12
UnitedHealth USD 3.26B 1.06B 2025-12
Veeva Systems USD 245.88M 5.02M 2025-12
Veradigm USD -45.47M 70.47M 2022-12
Xerox USD 30M 8M 2025-06